Cloning, expression and purification of the factor H binding protein and its interaction with factor H
,
Abstract
Background and Objective: Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. The factor H binding protein (fHBP) is a key virulence factor of Neisseria meningitidis that is able to selectively bind to human factor H, the key regulator of the alternative complement pathway, which it has important implications for meningococcal pathogene- sis and vaccine design. The aims of present research were cloning, expression, purification of fHbp and confirmation of the interaction between serum factor H (fH) and produced factor H binding protein.
Materials and Methods: A 820 base pairs fhbp gene fragment was amplified by PCR and cloned into expression vector pE- T28a (+) in Bam HI and SalI restriction enzymes sites. Recombinant DNA was expressed in BL21 (DE3) cell. fHBP protein was purified by Ni-NTA agarose resin. Coupling of recombinant protein into CNBr activated Sepharose 4B resin was carried out for application in serum fH protein purification. (fH-fHBP) interaction was confirmed by SDS-PAGE and far-western blotting.
Results and Conclusions: SDS-PAGE results showed a 35 kDa protein band. 150 kDa fH protein was purified by designed Sepharose 4B resin. Far-western blotting confirmed (fH-fHBP) interaction and proper folding of factor H binding protein.
Stephens DS. Biology and pathogenesis of the evolu- tionarily successful, obligate human bacterium Neisse- ria meningitidis. Vaccine 2009;27 Suppl 2:B71-7.
Masignani V, Comanducci M, Giuliani MM, Bambi- ni S, Adu-Bobie J, Arico B, et al. Vaccination against Neisseria meningitidis using three variants of the lipo- protein GNA1870. J Exp Med 2003;197:789-99.
Zipfel PF, Jokiranta TS, Hellwage J, Koistinen V, Meri S. The factor H protein family. Immunopharmacology 1999;42(1-3):53-60.
Diaz A, Ferreira A, Sim RB. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol 1997;158:3779-3786.
Madico G, Welsch JA, Lewis LA, McNaughton A, Per- lman DH, Costello CE, et al. The meningococcal vac- cine candidate GNA1870 binds the complement regu- latory protein factor H and enhances serum resistance. J Immunol 2006;177:501-510.
Sreenivas S, Krishnaiah SM, Govindappa N, Basavara- ju Y, Kanojia K, Mallikarjun N, et al. Enhancement in production of recombinant two-chain Insulin Glargine by over-expression of Kex2 protease in Pichia pastoris. Appl Microbiol Biotechnol 2015;99:327-336.
Ghodsi S, Gharavi S, Ghadam P. Cloning the hbs gene from Bacillus subtilis and expression of the HBsu protein in Escherichia coli. Iran J Microbiol 2010;2(3):152-6.
Nilsson OR, Lannergard J, Morgan BP, Lindahl G, Gustafsson MC. Affinity purification of human fac- tor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant. PloS one 2013;8(11):e81303.
Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria menin- gitidis. Lancet 2007;369(9580):2196-2210.
Wright V, Hibberd M, Levin M. Genetic polymor- phisms in host response to meningococcal infection: the role of susceptibility and severity genes. Vaccine 009;27 Suppl 2:B90-102.
Haralambous E, Dolly SO, Hibberd ML, Litt DJ, Udalova IA, O'Dwyer C, et al. Factor H, a regulator of complement activity, is a major determinant of me- ningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis 2006;38:764-771.
Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev icrobiol 2008;6:132-142.
Granoff DM, Welsch JA, Ram S. Binding of comple- ment factor H (f H) to Neisseria meningitidis is specific for human f H and inhibits complement activation by rat and rabbit sera. Infect Immun 2009;77:764-769.
Giuntini S, Beernink PT, Reason DC, Granoff DM.Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discor- dant functional activity. PloS one 2012;7(3):e34272.
Chou CP. Engineering cell physiology to enhance re- combinant protein production in Escherichia coli. Appl Microbiol Biotechnol. 2007;76:521-32.
Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expres- sion of cloned genes. J Mol Biol 1986;189:113-130.
Pio R, Elsasser TH, Martinez A, Cuttitta F. Identifi- cation, characterization, and physiological actions of factor H as an adrenomedullin binding protein present in human plasma. Microsc Res Tech 2002;57:23-27.
Schneider MC, Exley RM, Chan H, Feavers I, Kang YH, Sim RB, et al. Functional significance of fac- tor H binding to Neisseria meningitidis. J Immunol 2006;176:7566-775.
Berggard T, Linse S, James P. Methods for the detec- tion and analysis of protein-protein interactions. Pro- teomics 2007;7:2833-2842.
Ohba T, Ishino M, Aoto H, Sasaki T. Dot far-western blot analysis of relative binding affinities of the Src ho- mology 3 domains of Efs and its related proteins. Anal Biochem 1998;262:185-192.
| Files | ||
| Issue | Vol 8 No 1 (2016) | |
| Section | Articles | |
| Keywords | ||
| N. meningitidis fHbp cloning fH protein far-western blotting | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
